Page last updated: 2024-10-27

fluoxetine and Anemias, Iron-Deficiency

fluoxetine has been researched along with Anemias, Iron-Deficiency in 3 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Tatay-Manteiga, A1
Cravero, C1
Guinchat, V1
Barete, S1
Consoli, A1
Parish, JM1

Other Studies

3 other studies available for fluoxetine and Anemias, Iron-Deficiency

ArticleYear
Pica: obsessive-compulsive spectrum disorder, recurrent depression or eating disorder?
    Actas espanolas de psiquiatria, 2020, Volume: 48, Issue:2

    Topics: Adult; Anemia, Iron-Deficiency; Depression; Feeding and Eating Disorders; Female; Fluoxetine; Humans

2020
Cornelia de Lange and Ehlers-Danlos: comorbidity of two rare syndromes.
    BMJ case reports, 2016, Feb-01, Volume: 2016

    Topics: Adult; Anemia, Iron-Deficiency; Antidepressive Agents, Second-Generation; Cognitive Behavioral Thera

2016
"I can't sleep at night" an unusual case of insomnia.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2005, Jul-15, Volume: 1, Issue:3

    Topics: Aged; Anemia, Iron-Deficiency; Blood Transfusion; Colonic Neoplasms; Combined Modality Therapy; Cont

2005